NEUR.CO - NeuroSearch A/S

Copenhagen - Copenhagen Real Time Price. Currency in DKK
4.56
0.00 (0.00%)
At close: 4:54PM CEST
Stock chart is not supported by your current browser
Previous Close4.56
Open4.59
Bid4.56 x 0
Ask4.60 x 0
Day's Range4.56 - 4.68
52 Week Range2.80 - 5.20
Volume96,668
Avg. Volume122,131
Market Cap110.753M
Beta0.27
PE Ratio (TTM)N/A
EPS (TTM)-0.34
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est46.25
  • GlobeNewswire6 days ago

    Major shareholder announcement

    Company Announcement 14 September 2018. Pursuant to section 30 of Consolidated Act no. 12 of 8 January 2018 on capital markets, as amended, NeuroSearch A/S hereby announces to have received a major shareholder ...

  • GlobeNewswire6 days ago

    Report on Extraordinary General Meeting of NeuroSearch A/S

    Announcement 14 September 2018 At the company’ s Extraordinary General Meeting held today, the following resolution was passed: Morten Mathiesen and Mikkel Primdal Kæregaard were elected to the Board of ...

  • GlobeNewswire12 days ago

    NeuroSearch A/S receives notice of payment from Teva Pharmaceutical International GmbH regarding Pridopidine and changes financial outlook for 2018

    On 16 May 2018, NeuroSearch A/S ("NeuroSearch") entered into an agreement with, among others, Teva Pharmaceutical International GmbH ("Teva") (the "Agreement") to release Teva from all outstanding obligations pursuant to the agreement from 2012 concerning the transfer of NeuroSearch's rights in and to Pridopidine. NeuroSearch has been informed that Teva has completed a definitive agreement relating to the sale and transfer of Teva's right in and to Pridopidine with effect from 9 September 2018, and that NeuroSearch therefore pursuant to the Agreement will receive a cash payment of USD 450,000.

  • GlobeNewswire22 days ago

    NeuroSearch A/S – H1 report 2018

    Below please find the H1 report 2018. The full report is available in the enclosed PDF file. NeuroSearch posted an operating loss of DKK 2.8 million in H1 2018. NeuroSearch posted a net loss of DKK 3.0 ...

  • GlobeNewswire28 days ago

    Major shareholding announcement

    Company announcement 23 August 2018 Pursuant to section 30 of Consolidated Act no. 12 of 8 January 2018 on capital markets, as amended, NeuroSearch A/S hereby announces to have received a major shareholder ...

  • GlobeNewswirelast month

    Major shareholding announcement

    Company Announcement 16 August 2018 Pursuant to section 30 of Consolidated Act no. 12 of 8 January 2018 on capital markets, as amended, NeuroSearch A/S hereby announces to have received a major shareholder ...

  • GlobeNewswirelast month

    NeuroSearch announces change to financial outlook for 2018

    In Annual Report 2017, NeuroSearch announced a financial outlook, on a going concern assumption, of an operating loss in the range of DKK 3.5-4.5 million. In May 2018, NeuroSearch entered into an agreement with, among others, Teva Pharmaceutical International GmbH (Teva), to release Teva from all outstanding obligations pursuant to the agreement from 2012 concerning the transfer of NeuroSearch's rights in and to Pridopidine. According to the agreement entered into, in the event that Teva prior to 31 October 2018 enters into an agreement with an identified third party relating to the sale and transfer of Teva's rights in and to Pridopidine, then NeuroSearch will receive a cash payment of USD 450,000 (DKK 2.7 million).

  • GlobeNewswirelast month

    Major shareholding announcement

    Company Announcement 13 August 2018 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS ...

  • GlobeNewswirelast month

    Nordic Transport Group Holding A/S announces final result of takeover offer

    With reference to NeuroSearch A/S' ("NeuroSearch") announcement of 20 June 2018 (no. 12 - 18) regarding publication of the offer document concerning the voluntary public takeover offer to the shareholders of NeuroSearch from Nordic Transport Group Holding A/S ("NTG Holding") ("NTG Holding's Offer") and announcement of 9 August 2018 (no. 16 - 18) regarding publication of the preliminary result of NTG Holding's Offer, NTG Holding has today announced the final result of NTG Holding's Offer pursuant to section 21(3) of Danish Executive Order no. 1171/2017 on Takeover Bids. On the basis of the final calculation of received acceptances, NTG Holding has announced that NTG Holding at expiry of the offer period concerning NTG Holding's Offer has received acceptances of NTG Holding's Offer representing 4,331,686 shares of nominal DKK 1 corresponding to 17.64 percent of the entire share capital and all voting rights in NeuroSearch.

  • GlobeNewswirelast month

    Nordic Transport Group Holding A/S announces preliminary result of takeover offer

    With reference to NeuroSearch A/S' ("NeuroSearch") announcement of 20 June 2018 (no. 12 - 18) regarding publication of the offer document concerning the voluntary public takeover offer to the shareholders of NeuroSearch from Nordic Transport Group Holding A/S ("NTG Holding") ("NTG Holding's Offer"), NTG Holding has today announced the preliminary result of NTG Holding's Offer pursuant to section 21(3) of Danish Executive Order no. 1171/2017 on Takeover Bids. On the basis of a non-binding, preliminary calculation of received acceptances, NTG Holding has announced that NTG Holding at expiry of the offer period concerning NTG Holding's Offer has received acceptances of NTG Holding's Offer representing 4,312,332 shares of nominal DKK 1 corresponding to 17.56 percent of the entire share capital and all voting rights in NeuroSearch.

  • GlobeNewswirelast month

    Gefion Group Investments A/S announces final result and withdrawal of takeover offer

    With reference to NeuroSearch A/S' ("NeuroSearch") announcement of 25 May 2018 (no. 10 - 18) regarding publication of the offer document concerning the conditional, voluntary public takeover offer to the shareholders of NeuroSearch from Gefion Group Investments A/S ("Gefion") and announcement of 25 June 2018 (no. 13 - 18) regarding a supplement to the aforementioned offer document (together "Gefion's Offer"), Gefion has today announced the final result of Gefion's Offer pursuant to section 21(3) of Danish Executive Order no. 1171/2017 on Takeover Bids. Based on Gefion's final counting of acceptances, Gefion has announced that Gefion at expiry of the offer period concerning Gefion's Offer has received acceptances of Gefion's Offer representing 2,373,473 shares of nominal DKK 1 each corresponding to approx. 9.67 percent of the entire share capital and all voting rights in NeuroSearch.

  • GlobeNewswire4 months ago

    NeuroSearch A/S: Publication of offer document

    With reference to NeuroSearch A/S`s ("NeuroSearch") announcement of 27 April 2018 (no. 6 - 18) concerning a conditional, voluntary takeover offer to the shareholders of NeuroSearch to acquire the entire share capital of NeuroSearch (excluding any treasury shares) against cash consideration of DKK 4.00 per share (the "Offer"), Gefion Group Investments A/S ("Gefion") has today published an offer document and an acceptance form (attached to the offer document) pursuant to section 4(2) of Danish Executive Order no. 1171/2017 on Takeover Bids.

  • Why NeuroSearch A/S’s (CPH:NEUR) Ownership Structure Is Important
    Simply Wall St.5 months ago

    Why NeuroSearch A/S’s (CPH:NEUR) Ownership Structure Is Important

    In this analysis, my focus will be on developing a perspective on NeuroSearch A/S’s (CPSE:NEUR) latest ownership structure, a less discussed, but important factor. Ownership structure of a company hasRead More...